Navigation Links
Pacira Pharmaceuticals, Inc. Announces Key EXPAREL™ Data to be Presented at American College of Surgeons 97th Annual Clinical Congress
Date:10/18/2011

PARSIPPANY, N.J., Oct. 18, 2011 /PRNewswire/ -- Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX) today announced that new data discussing the pharmacoeconomic impact of EXPAREL™ (bupivacaine liposome extended-release injectable suspension), the company's lead investigational product for postsurgical pain management, will be presented during a podium presentation at the American College of Surgeons (ACS) 97th Annual Clinical Congress in San Francisco on Wednesday, October 26. Another podium presentation highlighting the pain control properties and related impact on opioid use of EXPAREL compared to bupivacaine HCl across three surgical models will be presented on Monday, October 24.

Currently under review with the U.S. Food and Drug Administration, EXPAREL is an innovative, long-acting bupivacaine that has been evaluated in multiple Phase 2 and Phase 3 clinical studies to assess prolonged postsurgical analgesia for up to 72 hours with a single-dose local administration into the surgical site. The drug combines bupivacaine with DepoFoam®, Pacira's proven product delivery technology that delivers medication over a desired time period.

The schedule for Pacira podium presentations are as follows:

Presentation Title: Comparison of Immediate-Release Bupivacaine vs. EXPAREL™ (Bupivacaine Extended-Release Liposome Injection) on Opioid Requirements and Related Adverse Events from Phase 2 and 3 Studies Utilizing Multimodal Analgesia Across Multiple Surgical Models

Presented by: Sonia Ramamoorthy, M.D., associate professor of surgery at the University of California, San Diego

Date & Time: Monday, October 24 from 9:45-11:15 a.m. PDT

Location: Moscone Convention Center, Moscone West, 3rd Floor, Room 3014/3016/3018

Presentation Title: EXPAREL™ (Bupivacaine
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pacira Pharmaceuticals, Inc. Announces Efficacy and Safety of EXPAREL™ Highlighted at "Hot Topics in Plastic Surgery" Panel at the 2011 Annual Meeting of the American Society of Plastic Surgeons
2. Pacira Pharmaceuticals, Inc. to Present at UBS Global Life Sciences Conference
3. Pacira Pharmaceuticals, Inc. Expands EXPAREL™ Commercial Team Infrastructure
4. Pacira Pharmaceuticals, Inc. to Present at Wedbush Securities 2011 Life Sciences Management Access Conference
5. Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results
6. Pacira Pharmaceuticals, Inc. Announces Data Presentations at the 38th Annual Meeting & Exposition of the Controlled Release Society
7. Pacira Pharmaceuticals, Inc. Announces Timing for Second Quarter 2011 Financial Results Webcast and Conference Call
8. Pacira Pharmaceuticals, Inc. Announces Inclusion in Russell 3000 Index
9. Pacira Pharmaceuticals, Inc. Announces FDA Extension of EXPAREL™ PDUFA Target Date by Three Months
10. Pacira Pharmaceuticals, Inc. Appoints Two Life Sciences Industry Veterans to Its Board of Directors
11. Pacira Pharmaceuticals, Inc. to Present at UBS Global Specialty Pharmaceuticals Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Commenting on GSK,s Q2 performance, ... Simon Dingemans reveals sales rose during the period ... with expectations. Ahead of a November R&D update day ... The interview and transcript are available now on ... documentaries and webcasts with senior company executives. If you ...
(Date:7/29/2015)... 2015 Cogentix Medical, Inc. (NASDAQ: CGNT ), ... will release financial results for the first quarter of fiscal ... close on Monday, August 10, 2015. The ... these results on Monday, August 10, 2015 at 4:30 p.m. ... President and Chief Executive Officer, and Brett Reynolds , ...
(Date:7/29/2015)... Calif. , July 29, 2015  Cepheid ... availability of an update to Xpert® Carba-R, with ... OXA-181 and OXA-232.  The on-demand, molecular test also ... mechanisms of carbapenem resistance, namely KPC, NDM, VIM, ... referred to as CROs or Superbugs, are a ...
Breaking Medicine Technology:Cogentix Medical to Announce First Quarter Fiscal 2016 Results on August 10, 2015 2'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 2'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 3'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 4
... N.J., Sept. 8 Today every major pharmaceutical industry ... the future of pharma.  In an unprecedented move, they,re ... the big names in pharma.  All in one place. ... at the Pharma CI Conference & Exhibition at the ...
... In honor of Cholesterol Education Month, The American ... role of the pharmacist in communities nationwide. In many ... pressure screenings, as well as other detection and prevention ... get the most out the medications they may be ...
Cached Medicine Technology:Pharmaceutical Industry Insiders, VIPs All Coming Together for Future of Pharma Market, Pharmaceutical Competitive Intelligence 2Pharmacists May Help Patients Prevent and Detect Heart Disease 2Pharmacists May Help Patients Prevent and Detect Heart Disease 3
(Date:7/29/2015)... Los Angeles, CA (PRWEB) , ... July 29, 2015 , ... We are privileged to ... at Keck Medicine of USC as the ninth best ophthalmology hospital in the nation for ... the top 10 American hospitals for ophthalmology. , “It is an honor to be ...
(Date:7/29/2015)... , ... July 29, 2015 , ... July is National UV Awareness Month, and in ... DC shares tips on how to protect skin from the sun, as well as how ... cancer, and is one of the most common skin conditions in America. Many people do ...
(Date:7/29/2015)... ... 29, 2015 , ... It is unique for a health center to dedicate ... care. One that is very hands on and resident oriented, and one to which ... bringing great passion and energy, as well as a strong commitment to helping seniors ...
(Date:7/29/2015)... Palatine, IL (PRWEB) , ... July 29, 2015 , ... ... the ever-expanding population of children with autism, Little City took a proactive stance and ... and occupied. The Coleman Foundation grant provides valuable support to building the third home. ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... a decision from the Judicial Panel on Multidistrict Litigation (JPML), according to court ... defects research at their website, the Zofran Birth Defects Lawsuit Center. , GlaxoSmithKline, ...
Breaking Medicine News(10 mins):Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 3Health News:New Medical Director Readies To Take Reins at Monarch Landing 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 3Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4
... improved sleep for patients with chronic neck or back ... interfered with their daily functioning, according to a study ... study, published online by the journal Sleep Medicine, ... who already are taking medications for pain and might ...
... , OMAHA, Neb. , Feb. 11 ... dental technology developed to improve human dental health for two ... Cleaning Paste and the Petrodex® Tooth-Hugger Toothbrush. The Petrodex Tooth-Hugger ... Petrodex Ultra Advanced Veterinary Cleaning Paste will be available in ...
... , Idiopathic Pulmonary Fibrosis (IPF) ... SAN JOSE, Calif. , Feb. 11 ... Commissioner Michael Astrue ,s announcement this morning via press ... Fibrosis (PF), and a listing of 37 other diseases and ...
... PITTSBURGH, Feb. 11 Patients admitted to hospitals with ... hospitals with low-intensity approaches, according to a University of ... issue of the journal Medical Care. Higher-intensity care refers ... admission, intubation or mechanical ventilation, kidney dialysis and feeding ...
... finds less than 1% use it as preventative; experts say drug ... -- Only a tiny fraction of women at high risk of ... This news comes despite the fact that experts have known since ... by almost 50 percent. , "This is not a surprise to ...
... ... FAB-HOMES ™, a green home design studio based in Vancouver, Canada, is ... market. Fab-homes™ showcases a selection of modern, European dwellings planned along the ... 90% less energy for heating, cooling and building operation than a standard ...
Cached Medicine News:Health News:Behavioral therapy improves sleep and lives of patients with pain 2Health News:Human Dental Technology Leads to Breakthroughs for Pet Dental Health at Sergeant's Pet Care Products, Inc. 2Health News:Human Dental Technology Leads to Breakthroughs for Pet Dental Health at Sergeant's Pet Care Products, Inc. 3Health News:Patients with Lethal Lung Disease Finally Receive Recognition by Social Security Administration 2Health News:Patients with Lethal Lung Disease Finally Receive Recognition by Social Security Administration 3Health News:Survival benefit with high-intensity end-of-life approaches 2Health News:Few Women at High Risk for Breast Cancer Take Tamoxifen 2Health News:Few Women at High Risk for Breast Cancer Take Tamoxifen 3Health News:FAB-HOMES™ Presents First Passive House Collection 2Health News:FAB-HOMES™ Presents First Passive House Collection 3
The CapSureFix line of pacing leads combines the benefits of steroid-eluting technology with screw-in active fixation, to allow long-lasting, low-threshold delivery of pacing therapies....
... is a low profile implantable bipolar ... stimulation of either the atrium (preformed ... model). All ZY leads are supplied ... used to extend/retract the fixation helix ...
... leads are small profile endocardial permanent pacing ... a lead body size of only 4.8 ... 7 F, the Physique lead is the ... Available in both straight and pre-formed J ...
Used with Temporary Myocardial Heartwires....
Medicine Products: